ArticleBMJ open2026
Association of time of day at stroke onset with functional outcomes after reperfusion therapy in acute ischaemic stroke: a retrospective cohort study in China.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the association between the time of day of stroke onset and functional outcomes among patients with acute ischaemic stroke who received reperfusion therapy.
designRetrospective cohort study.
settingPatients with acute ischaemic stroke who received reperfusion therapy (intravenous thrombolysis or combined endovascular therapy) between October 2018 and March 2022 in China were included.
participantsA total of 712 patients with acute ischaemic stroke receiving reperfusion therapy were included. Patients were categorised into two groups (day-onset (06:00-18:00) and night-onset (18:00-06:00)) and into six groups by 4-hour intervals. OUTCOME MEASURES: The primary outcome was the 3-month functional status, evaluated using the modified Rankin Scale, with scores of 0-2 classified as favourable and scores of 3-6 as unfavourable outcomes. Propensity score matching (PSM), inverse probability of treatment weighting (IPTW) and overlap weighting (OW) were used for analyses.
results148 out of 286 patients (51.7%) in the night-onset group and 182 out of 426 patients (42.7%) in the day-onset group experienced unfavourable outcomes at 3 months. Night-onset stroke was associated with a significantly higher risk of unfavourable outcome compared with day-onset stroke (OR 1.44 (95% CI 1.06 to 1.94), p=0.018). This association remained significant after adjustment using PSM (OR 1.45 (95% CI 1.01 to 2.08), p=0.044), and was further confirmed in analyses using IPTW (OR 1.42 (95% CI 1.02 to 1.96), p=0.036), OW (OR 1.42 (95% CI 1.03 to 1.96), p=0.032) and multivariable adjustment (adjusted OR 1.55 (95% CI 1.07 to 2.22), p=0.019). Night-onset stroke during 22:00-02:00 (adjusted OR 2.44 (95% CI 1.34 to 4.43), p=0.003) was significantly associated with a higher likelihood of unfavourable outcome in adjusted analysis.
conclusionsNight-onset stroke was associated with poorer functional outcomes at 3 months among patients receiving reperfusion therapy. Further multicentre prospective studies are warranted to validate these findings. TRIAL REGISTRATION NUMBER: Chinese Clinical Trial Registry Identifier: ChiCTR2500101844.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.